The Centers for Medicare & Medicaid Services (CMS) has opened the 2023 Doctors and Clinicians Preview Period, which runs from May 27, 2025, to June 25, 2025 at 8 pm ET.
During this time, you can preview your 2023 Quality Payment Program (QPP) performance data before it becomes publicly available on the Medicare Care Compare tool and the CMS Provider Data Catalog.
CMS selects performance data based on what they think will be most meaningful for patients and caregivers. This includes certain 2023 MIPS Quality and Promoting Interoperability (PI) measures, as well as some Improvement Activities (IA) attestations.
Which Measures Will Be Publicly Reported?
CMS will publish data for 135 quality measures on the Medicare Care Compare tool. Performance on each of these measures will be displayed as a star rating on the individual clinician and/or group profile page.
We’ve listed the quality measures most relevant to our clients below, starting with measures that are generally applicable to most clinicians, followed by lists organized alphabetically by specialty. Most measures will be displayed on Care Compare for both group and individual reporters. However, some are specific to one reporting type only. These will be marked with “group only” or “individual only” next to the measure name.
Click on the dropdowns to view measures relevant to each specialty as well as general measures.
Note: There are additional quality measures that will be posted on the CMS Provider Data Catalog, but these files are largely accessed by researchers rather than patients. You can view the full list in the CMS Summary of 2023 QPP Publicly Reported Performance Information (PDF).
2023 General Quality Measures for Public Reporting
- 1: Diabetes: Glycemic Status Assessment Greater Than 9%
- 47: Advance Care Plan
- 107: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
- 128: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
- 130: Documentation of Current Medications in the Medical Record
- 134: Preventive Care and Screening: Screening for Depression and Follow-Up Plan
- 226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
- 236: Controlling High Blood Pressure
- 238: Use of High-Risk Medications in Older Adults (group only)
- 240: Childhood Immunization Status (group only)
- 281: Dementia: Cognitive Assessment (group only)
- 286: Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia (group only)
- 310: Chlamydia Screening for Women (individual only)
- 317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
- 318: Falls: Screening for Future Fall Risk
- 374: Closing the Referral Loop: Receipt of Specialist Report
- 382: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment (group only)
- 400: One-Time Screening for Hepatitis C Virus (HCV) and Treatment Initiation
- 402: Tobacco Use and Help with Quitting Among Adolescents
- 431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
- 475: HIV Screening
- 479: Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS (group only)
2023 Dermatology and Plastic Surgery Quality Measures for Public Reporting
- 176: Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy (individual only)
- 356: Unplanned Hospital Readmission within 30 Days of Principal Procedure (Plastic Surgery)
- 358: Patient-Centered Surgical Risk Assessment and Communication (Plastic Surgery)
- 410: Psoriasis: Clinical Response to Systemic Medications (group only)
- AAD6: Skin Cancer: Biopsy Reporting Time – Clinician to Patient
- AAD7: Psoriasis: Screening for Psoriatic Arthritis (group only)
2023 Ophthalmology Quality Measures for Public Reporting
- 12: Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation (group only)
- 14: Age-Related Macular Degeneration (AMD): Dilated Macular Examination
- 19: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
- 117: Diabetes: Eye Exam
- 384: Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room within 90 Days of Surgery
- 385: Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement within 90 Days of Surgery (individual only)
- 389: Cataract Surgery: Difference Between Planned and Final Refraction
2023 Orthopedic Surgery and Podiatry Quality Measures for Public Reporting
- 24: Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older
- 39: Screening for Osteoporosis for Women Aged 65-85 Years of Age
- 126: Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy – Neurological Evaluation
- 127: Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear (individual only)
- 182: Functional Outcome Assessment
- 318: Falls: Screening for Future Fall Risk
- 350: Total Knee or Hip Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy
- 351: Total Knee or Hip Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation (individual only)
- 356: Unplanned Hospital Readmission within 30 Days of Principal Procedure
- 358: Patient-Centered Surgical Risk Assessment and Communication
- 418: Osteoporosis Management in Women Who Had a Fracture (group only)
- 480: Risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) for MIPS
- REGCLR3: Bunion Outcome – Adult and Adolescent (individual only)
2023 ENT Quality Measures for Public Reporting
- 65: Appropriate Treatment for Upper Respiratory Infection (URI)
- 66: Appropriate Testing for Pharyngitis (group only)
- 277: Sleep Apnea: Severity Assessment at Initial Diagnosis (group only)
- 318: Falls: Screening for Future Fall Risk
- 331: Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)
- 332: Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use) (group only)
- 356: Unplanned Hospital Readmission within 30 Days of Principal Procedure
- 358: Patient-Centered Surgical Risk Assessment and Communication
- 398: Optimal Asthma Control
- 464: Otitis Media with Effusion: Systemic Antimicrobials – Avoidance of Inappropriate Use (group only)
- AAO23: Allergic Rhinitis: Intranasal Corticosteroids or Oral Antihistamines
2023 PT/OT Quality Measures for Public Reporting
- 48: Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older
- 50: Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older (group only)
- 126: Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy – Neurological Evaluation
- 127: Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear (individual only)
- 182: Functional Outcome Assessment
- 217: Functional Status Change for Patients with Knee Impairments (individual only)
- 218: Functional Status Change for Patients with Hip Impairments (individual only)
- 220: Functional Status Change for Patients with Low Back Impairments (individual only)
- 221: Functional Status Change for Patients with Shoulder Impairments (individual only)
- 318: Falls: Screening for Future Fall Risk
- 478: Functional Status Change for Patients with Neck Impairments
2023 Rheumatology Quality Measures for Public Reporting
- 24: Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older
- 39: Screening for Osteoporosis for Women Aged 65-85 Years of Age
- 176: Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy (individual only)
- 177: Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity
- 178: Rheumatoid Arthritis (RA): Functional Status Assessment (individual only)
- 180: Rheumatoid Arthritis (RA): Glucocorticoid Management (group only)
- 182: Functional Outcome Assessment
How Do I Preview My Performance Data?
You can preview your performance data by logging in to your QPP account. For detailed step-by-step instructions on how to access the preview, refer to the CMS 2023 Performance Information Preview Period Guide (PDF).
Next Steps
- Share this information with your colleagues.
- Subscribe to our blog to get alerts on this and other important issues. You can subscribe using the field in our website footer below.
- If you are an Anatomy IT client, contact your MIPS Expert if you have any questions.
- If you are not an Anatomy IT client, contact us to learn more about our MIPS Success Plan and to reap the rewards of our combined decades of experience.
If you have any questions on this, let us know!
**
Written By: **Sarrah Hakim, MHSA
About the Author: Sarrah is a Manager of Health Policy at Anatomy IT.